Rapport Therapeutics
Signal active
Organization
Contact Information
Overview
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.
About
Industries
Biotechnology, Life Science, Health Care, Medical, Precision Medicine
Founded
2022
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Rapport Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Medical, Precision Medicine sector. The company focuses on Biotechnology and has secured $10.0B in funding across 40 round(s). With a team of 11-50 employees, Rapport Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Rapport Therapeutics, raised $150.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
11
Lead Investors
0
Total Funding Amount
$250.0M
Details
2
Rapport Therapeutics has raised a total of $250.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 100.0M | ||
| 2023 | Early Stage Venture | 150.0M |
Investors
Rapport Therapeutics is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| James Healy | - | FUNDING ROUND - James Healy | 150.0M |
| Sofinnova Investments | - | FUNDING ROUND - Sofinnova Investments | 150.0M |
| Rapport Therapeutics | - | FUNDING ROUND - Rapport Therapeutics | 150.0M |
| T. Rowe Price | - | FUNDING ROUND - T. Rowe Price | 150.0M |
Recent Activity
There is no recent news or activity for this profile.